Fig. 1
From: Immunological Detection of a Novel Advanced Glycation End-Product
Immunoreactivity of AGE-6 antiserum. The immunoreactivity of AGE-6 antiserum with AGE-BSA (○, AGE-6) CML-BSA (△), and native BSA (●) was determined at various concentrations by competitive ELISA. Details are described in Materials and Methods. (A): non-competitive ELISA employing bound ligand. (B): competitive ELISA employing bound ligand, and AGE-BSA, CML-BSA, or unmodified BSA as competitors.